A retrospective STUDY of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome

Human Reproduction

Volumn 29, Issue 10, 2014, Pages 2333-2338

  De Frene V ^a   Vansteelandt, S ^b   T'sjoen, G ^a   Gerris, J ^a   Somers, S ^a   Vercruysse, L ^a   De Sutter, P ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Delivery; Newborn; Overweight; Polycystic ovary syndrome; Pregnancy complications

Indexed keywords

INSULIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; GROUPS BY AGE; HUMAN; INFERTILITY THERAPY; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; OBSTETRIC DELIVERY; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; RETROSPECTIVE STUDY; SMOKING; TESTOSTERONE BLOOD LEVEL; TIME TO PREGNANCY; BIRTH WEIGHT; BODY MASS; COMPLICATION; NEWBORN; PREGNANCY; PREMATURITY;

ADULT; BIRTH WEIGHT; BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; INFANT, NEWBORN; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; RETROSPECTIVE STUDIES; TIME-TO-PREGNANCY;

EID: 84907902698     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu154     Document Type: Article

References (36)

1. Altieri P, Gambineri A, Prontera O, Cionci G, Franchina M, Pasquali R. Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2010;149:31-36.
2. American Diabetes Association. Gestational Diabetes Mellitus. Consulted at 27 March 2014 on http://care.diabetesjournals.org/content/26/suppl-1/s103/T1.expansion. html.
3. Blomberg M. Maternal obesity, mode of delivery, and neonatal outcome. Obstet Gynecol 2013;122:50-55.
4. Bogaerts A, Van den Bergh B, Nuyts E, Martens E, Witters I, Devlieger R. Socio-demographic and obstetrical correlates of pre-pregnancy body mass index and gestational weight gain. Clin Obes 2012;2:150-159.
5. Boomsma CM, Eijkemans MJC, Hughes EG, Visser GHA, Fauser B C JM, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod 2006;12:673-683.
6. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113:1210-1217.
7. Cnattingius S, Villamor E, Johansson S, Edstedt Bonamy AD, Persson M, Wikström AK, Granath F. Maternal obesity and risk of preterm delivery. JAMA 2013;309:2362-2370.
8. Crane JM, Murphy P, Burrage L, Hutchens D. Maternal and perinatal outcomes of extreme obesity in pregnancy. J Obstet Gynaecol Can 2013;35:606-611.
9. Delbaere I, Verstraelen H, Goetgeluk S, Martens G, De Backer G, Temmerman M. Pregnancy outcome in primiparae of advanced maternal age. Eur J Obstet Gynecol Reprod Biol 2007;135:41-46.
10. Dhont M, De Sutter P, Ruyssinck G, Martens G, Bekaert A. Perinatal outcome of pregnancies after assisted reproduction: a case-control study. Am J Obstet Gynecol 1999;181:688-695.
11. Fedorscák P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000;79:43-48.
12. Han AR, Kim HO, Cha SW, Park CW, Kim JY, Yang KM, Song IO, Koong MK, Kang IS. Adverse pregnancy outcomes with assisted reproductive technology in non-obese women with polycystic ovary syndrome: a case-control study. Clin Exp Reprod Med 2011;38:103-108.
13. Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 2004;82:421-429.
14. Jewell NP. Statistics for Epidemiology. 1st edn. New York: Chapman & Hall, 2003.
15. Kazerooni T, Ghaffarpasand F, Asadj N, Dehkhoda Z, Dehghankhalilj M, Kazerooni Y. Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome: a comparative study. J Chin Med Assoc 2013;76:282-288.
16. Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a metaanalysis. Am J Obstet Gynecol 2011;204:558.e1-558.e6.
17. Land JA. How should we report on perinatal outcome? Hum Reprod 2006;21:2638-2639.
18. Lowe JB, Balanda KP, Clare G. Evaluation of antenatal smoking cessation programs for pregnant women. Aust N Z J Public Health 1998;22:55-59.
19. Maman E, Lunenfeld E, Levy A, Vardi H, Potashnik G. Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 1998;70:240-245.
20. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovary syndrome. Hum Reprod 2001;16:226-229.
21. Okon MA, Laird SM, Tuckerman EM, Li TC. Serumandrogen levelsin women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril 1998;69:682-690.
22. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 2006;113:1148-1159.
23. Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L. Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normo-glycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord 2006;6:19.
24. Perciaccante A, Fiorentini A, Valente R, Tubani L. Polycystic ovary syndrome: androgens, autonomic nervous system, and hypertension. Hypertension 2007;50:e7.
25. Qin JZ, Pang LH, Li MJ, Fan XJ, Huang RD, Chen HY. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol 2013;11:56.
26. Regan L, Owen EJ, Jacobs HS. Hyper secretion of luteinizing hormone, infertility, and miscarriage. Lancet 1990;336:1141-1144.
27. Rosenbaum PR. The consequences of adjustment for aconcomitant variable that has been affected by the treatment. J R Stat Soc Ser A 1984;147:656-666.
28. Scherrer U, Randin D, Tappy L, Vollenweider P, Jéquier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994;89:2634-2640.
29. Studen KB, Sever MJ, Pfeifer M. Cardiovascular risk and subclinical cardiovascular disease in polycystic ovary syndrome. In: Macut D, Pfeifer M, Yildiz BO, Diamanti-Kandarakis E (eds) Polycystic Ovary Syndrome: Novel Insights into Causes and Therapy. Front Horm Res. Vol. 40. Basel, Switzerland: Karger, 2013, 64-82.
30. The ESHRE Capri Workshop Group. Multiple gestation pregnancy. Hum Reprod 2000;15:1856-1864.
31. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
32. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991;17:669-677.
33. Turhan NO, Seçkin NC, Aybar F, Inegöl L. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynaecol Obstet 2003;81:163-168.
34. Vrbikova J, Hainer V. Obesity and polycystic ovary syndrome. Obes Facts 2009;2:26-35.
35. Wang JX, Davies MJ, Norman RJ. Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001;16:2606-2609.
36. World Health Organization. Health Topics: Obesity. Consulted at 23 November 2010. http://www.who.int/topics/obesity/en/.